y 27632 has been researched along with cilostazol in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (cilostazol) | Trials (cilostazol) | Recent Studies (post-2010) (cilostazol) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 1,508 | 302 | 848 |
| Protein | Taxonomy | y 27632 (IC50) | cilostazol (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.4367 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, KW; Kim, CD; Kwon, SM; Lee, SJ; Lee, SW; Lee, WS; Park, SY; Rhim, BY | 1 |
1 other study(ies) available for y 27632 and cilostazol
| Article | Year |
|---|---|
RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Topics: ADP Ribose Transferases; Amides; Animals; Arthritis, Rheumatoid; Botulinum Toxins; Case-Control Studies; Cilostazol; Cyclic AMP; Humans; Interleukin-23; Knee Joint; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred DBA; NF-kappa B; Nitriles; Pyridines; Reference Values; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Sulfones; Synovial Fluid; Teichoic Acids; Tetrazoles; Thionucleotides; Toll-Like Receptor 2 | 2013 |